Drug (if Trial Patent No. Filed Date Petitioner(s) Patent Owner(s) Inst. Dec. Outcome Details of FWD applicable) <Information obtained primarily from Lex Machina™ and public sources on the Internet. If any errors are identified, please contact Lisa Mandrusiak at Oblon.> IPR2015-00005 Cardene® 8,455,524 1-Oct-14 Sandoz Inc. EKR Therapeutics, LLC Denied N/A N/A IPR2015-00006 Cardene® 7,612,102 1-Oct-14 Sandoz Inc. EKR Therapeutics, LLC Denied N/A N/A IPR2015-00007 7,659,290 1-Oct-14 Sandoz Inc. EKR Therapeutics, LLC Denied N/A N/A IPR2015-00008 Cardene® 7,659,291 1-Oct-14 Sandoz Inc. EKR Therapeutics, LLC Denied N/A N/A Oxford Nanopore UAB Research Foundation; Claims disclaimed; final IPR2015-00057 8,673,550 13-Oct-14 Technologies Ltd. The University of Washington Instituted written decision Some claims upheld Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00131 6,468,967 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Agila Specialties Inc.; Mylan IPR2015-00132 6,852,689 23-Oct-14 Pharmaceuticals, Inc. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00140 8,129,342 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00141 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00142 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00143 8,058,238 23-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A Mylan Pharmaceuticals, Inc.; Mylan Laboratories Ltd.; Mylan, Inc.; Mylan Institutional Inc.; Agila Specialties Inc.; Agila IPR2015-00144 8,058,238 24-Oct-14 Specialties Private Ltd. Cubist Pharmaceuticals, Inc. N/A Settled pre-institution N/A University of Utah Research IPR2015-00152 5,747,282 24-Oct-14 GeneDx, Inc. Foundation N/A Settled pre-institution N/A University of Utah Research Foundation; HSC Research and Development Limited Partnership; Trustees of the Bio-Reference Laboratories, University of Pennsylvania; IPR2015-00154 5,837,492 24-Oct-14 Inc.; GeneDx, Inc. Endorecherche N/A Settled pre-institution N/A BioDelivery Sciences IPR2015-00165 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld BioDelivery Sciences IPR2015-00167 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Denied N/A N/A BioDelivery Sciences IPR2015-00168 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld BioDelivery Sciences IPR2015-00169 8,765,167 28-Oct-14 International, Inc. MonoSol Rx LLC Instituted Final written decision All inst. claims upheld IPR2015-00170 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/A N/A IPR2015-00171 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/A N/A IPR2015-00173 8,076,507 28-Oct-14 Daicel Corporation Celanese International Corp. Denied N/AN/A IPR2015-00223 6,852,689 3-Nov-14 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. Instituted Final written decision unpatentable IPR2015-00227 6,468,967 3-Nov-14 Fresenius Kabi USA, LLC Cubist Pharmaceuticals, Inc. Instituted Final written decision Some claims settled, some Merial Limited; University of Ceva Sante Animale S.A.; Saskatchewan; The Queen's IPR2015-00254 6,517,843 10-Nov-14 Biomune Company University of Belfast Instituted Claims disclaimed N/A Roche Molecular Systems, Inc.; Mayo Foundation for Medical Education and IPR2015-00255 5,643,723 10-Nov-14 Cepheid Research Denied N/A N/A Mylan, Inc.; Mylan Pharmaceuticals, Inc.; Mylan LTS Lohmann Therapie- IPR2015-00265 Exelon® 6,316,023 13-Nov-14 Technologies, Inc. Systeme AG; Novartis AG Instituted Final written decision All inst. claims unpatentable Mylan Technolgies, Inc; Mylan Pharmaceuticals, Inc.; Mylan, Novartis AG; LTS Lohmann IPR2015-00268 Exelon® 6,335,031 13-Nov-14 Inc. Therapie-Systeme AG Instituted Final written decision All inst. claims unpatentable ALETHIA BIOTHERAPEUTICS IPR2015-00291 8,168,181 25-Nov-14 Daiichi Sankyo Co., Ltd. INC. Instituted Final written decision All inst. claims unpatentable Rinat Neuroscience Corp.; IPR2015-00293 8,173,127 24-Nov-14 Pfizer, Inc. Intellect Neurosciences, Inc. N/A Settled pre-institution N/A Tissue Transplant Technology, Ltd.; Human Biologics of IPR2015-00320 8,709,494 1-Dec-14 Texas, Ltd. MiMedx Group, Inc. Denied N/A N/A IPR2015-00405 Lexiva® 6,436,989 10-Dec-14 Lupin Ltd. Vertex Pharmaceuticals Inc. Instituted Claims disclaimed N/A Namenda XR®; Ranbaxy Inc.; Ranbaxy IPR2015-00410 Namzaric™ 8,362,085 18-Dec-14 Laboratories Ltd. Adamas Pharmaceuticals Inc. N/A Settled pre-institution N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00415 Rituxan™ 7,820,161 15-Dec-14 Pharmaceuticals, Inc. Inc. Instituted Claims disclaimed N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00417 Rituxan™ 7,976,838 15-Dec-14 Pharmaceuticals, Inc. Inc. Instituted Claims disclaimed N/A Boehringer Ingelheim International GMBH; Boehringer Ingelheim Biogen Idec, Inc.; Genentech, IPR2015-00418 Rituxan™ 8,329,172 15-Dec-14 Pharmaceuticals, Inc. Inc. Denied N/A N/A Apotex Holdings, Inc.; Apotex IPR2015-00419 Emend® 5,691,336 11-Dec-14 Inc. Merck Sharp & Dohme Corp. Denied N/A N/A Tissue Transplant Technology, Ltd.; Human Biologics of IPR2015-00420 8,597,687 11-Dec-14 Texas, Ltd. MiMedx Group, Inc. Instituted Final written decision All inst. claims unpatentable Mylan, Inc.; Onco Therapies Ltd.; Agila Specialties Inc.; IPR2015-00503 Treanda® 8,436,190 24-Dec-14 Mylan Laboratories Ltd. Cephalon, Inc. Instituted Settled post-institution N/A Mylan Pharmaceuticals, Inc.; Mitsubishi Pharma Corp.; IPR2015-00518 Gilenya™ 8,324,283 31-Dec-14 Apotex Inc. Novartis AG Instituted Final written decision All inst. claims unpatentable Praxair, Inc.; Praxair IPR2015-00522 INOmax® 8,282,966 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00524 INOmax® 8,293,284 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00525 INOmax® 8,431,163 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00526 INOmax® 8,795,741 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Denied N/A N/A Praxair, Inc.; Praxair IPR2015-00529 INOmax® 8,846,112 5-Jan-15 Distribution, Inc. INO Therapeutics LLC Instituted Final written decision Some claims upheld Trizivir®; Epzicom®; Teva Pharmaceuticals USA, ViiV Healthcare Company; Viiv IPR2015-00550 Triumeq® 6,417,191 8-Jan-15 Inc. Healthcare UK Ltd. Denied Time barred N/A Boston Heart Diagnostics Health Diagnostic Laboratory, IPR2015-00557 8,119,358 13-Jan-15 Corp. Inc. Denied N/A N/A Cialis®; IPR2015-00561 Adcirca® 7,182,958 13-Jan-15 Actelion Pharmaceuticals Ltd. ICOS Corp. Instituted Final written decision All inst. claims unpatentable Cialis®; IPR2015-00562 Adcirca® 6,821,975 13-Jan-15 Actelion Pharmaceuticals Ltd. ICOS Corp. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-00643 Copaxone® 8,232,250 6-Feb-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Amneal Pharmaceuticals Co. Yeda Research and IPR2015-00644 Copaxone® 8,399,413 7-Feb-15 GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable Musculoskeletal Transplant Foundation; Liventa Bioscience, Inc.; Medline IPR2015-00664 8,372,437 2-Feb-15 Industries, Inc. MiMedx Group, Inc. Instituted Final written decision All inst. claims unpatentable Musculoskeletal Transplant Foundation; Liventa Bioscience, Inc.; Medline IPR2015-00669 8,323,701 2-Feb-15 Industries, Inc. MiMedx Group, Inc. Denied N/A N/A LO Loestrin® Mylan, Inc.; Mylan FE; LO Pharmaceuticals, Inc.; US Warner Chicott (US), LLC; IPR2015-00682 Minastrin® FE 7,704,984 3-Feb-15 Family Care Walter-Chilcott Co. LLC N/A Settled pre-institution N/A IPR2015-00715 Diprivan® 8,476,010 6-Feb-15 Dr. Reddy's Laboratories, Inc. Fresenius Kabi USA, LLC N/A Settled pre-institution N/A J Kyle Bass; Hayman Credes IPR2015-00720 Ampyra® 8,663,685 10-Feb-15 Master Fund, LP; et al. Acorda Therapeutics Inc. Denied N/A N/A Takeda Pharmaceutical Co. IPR2015-00754 8,592,454 17-Feb-15 Array Biopharma Inc. Ltd. Instituted Final written decision All inst. claims unpatentable Dr. Reddy's Laboratories, Inc.; Horizon Pharma PLC; Pozen IPR2015-00802 Vimovo® 8,557,285 24-Feb-15 Dr. Reddy's Laboratories, Ltd. Inc. Denied N/A N/A J Kyle Bass; Hayman Credes IPR2015-00817 Ampyra® 8,007,826 27-Feb-15 Master Fund, LP; et al. Acorda Therapeutics Inc. Denied N/A N/A Amneal Pharmaceuticals LLC; Mylan Pharmaceuticals, Inc.; Mylan Teoranta; Mylan Inc.; Mylan N.V.; Amneal Yeda Research and IPR2015-00830 Copaxone® 8,969,302 3-Mar-15 Pharmaceuticals Co. GmbH Development Co. Ltd. Instituted Final written decision All inst. claims unpatentable IPR2015-00858 Combigan® 7,030,149 9-Mar-15 Ferrum Ferro Capital, LLC Allergan Sales, LLC Denied N/A N/A Cadila Healthcare Ltd.; Amneal Pharmaceuticals LLC; Dr.